nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—FSHR—seminiferous tubule of testis—hypothyroidism	0.131	0.194	CbGeAlD
Suramin—FSHR—Hormone ligand-binding receptors—TSHB—hypothyroidism	0.0476	0.145	CbGpPWpGaD
Suramin—FSHR—Hormone ligand-binding receptors—TSHR—hypothyroidism	0.0476	0.145	CbGpPWpGaD
Suramin—SIRT1—brown adipose tissue—hypothyroidism	0.0434	0.0646	CbGeAlD
Suramin—P2RX4—nerve—hypothyroidism	0.0216	0.0322	CbGeAlD
Suramin—SIRT1—nerve—hypothyroidism	0.0189	0.0282	CbGeAlD
Suramin—F2—urine—hypothyroidism	0.0145	0.0216	CbGeAlD
Suramin—P2RY2—cardiovascular system—hypothyroidism	0.013	0.0193	CbGeAlD
Suramin—PLA2G2A—tongue—hypothyroidism	0.013	0.0193	CbGeAlD
Suramin—FSHR—gonad—hypothyroidism	0.0111	0.0165	CbGeAlD
Suramin—FSHR—pituitary gland—hypothyroidism	0.0108	0.0161	CbGeAlD
Suramin—P2RY2—blood—hypothyroidism	0.0103	0.0153	CbGeAlD
Suramin—FSHR—Peptide GPCRs—TSHR—hypothyroidism	0.0096	0.0292	CbGpPWpGaD
Suramin—FSHR—female gonad—hypothyroidism	0.00899	0.0134	CbGeAlD
Suramin—SIRT5—heart—hypothyroidism	0.00849	0.0126	CbGeAlD
Suramin—P2RX4—heart—hypothyroidism	0.00803	0.012	CbGeAlD
Suramin—SIRT5—cardiovascular system—hypothyroidism	0.00801	0.0119	CbGeAlD
Suramin—FSHR—testis—hypothyroidism	0.00797	0.0119	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.00754	0.023	CbGpPWpGaD
Suramin—FSHR—cerebellum—hypothyroidism	0.00736	0.011	CbGeAlD
Suramin—SIRT1—adrenal cortex—hypothyroidism	0.00727	0.0108	CbGeAlD
Suramin—SIRT5—gonad—hypothyroidism	0.00727	0.0108	CbGeAlD
Suramin—SIRT5—pituitary gland—hypothyroidism	0.00709	0.0106	CbGeAlD
Suramin—SIRT1—heart—hypothyroidism	0.00703	0.0105	CbGeAlD
Suramin—ARSA—heart—hypothyroidism	0.00695	0.0103	CbGeAlD
Suramin—P2RX4—pituitary gland—hypothyroidism	0.00671	0.00999	CbGeAlD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00668	0.0203	CbGpPWpGaD
Suramin—SIRT1—cardiovascular system—hypothyroidism	0.00664	0.00988	CbGeAlD
Suramin—RYR1—heart—hypothyroidism	0.0065	0.00968	CbGeAlD
Suramin—FSHR—G alpha (s) signalling events—TSHB—hypothyroidism	0.00635	0.0193	CbGpPWpGaD
Suramin—FSHR—G alpha (s) signalling events—TSHR—hypothyroidism	0.00635	0.0193	CbGpPWpGaD
Suramin—SIRT5—adrenal gland—hypothyroidism	0.00633	0.00943	CbGeAlD
Suramin—SIRT5—blood—hypothyroidism	0.00633	0.00943	CbGeAlD
Suramin—RYR1—cardiovascular system—hypothyroidism	0.00613	0.00913	CbGeAlD
Suramin—SIRT5—thyroid gland—hypothyroidism	0.00611	0.0091	CbGeAlD
Suramin—SIRT1—gonad—hypothyroidism	0.00602	0.00897	CbGeAlD
Suramin—P2RX4—adrenal gland—hypothyroidism	0.00599	0.00892	CbGeAlD
Suramin—P2RX4—blood—hypothyroidism	0.00599	0.00892	CbGeAlD
Suramin—ARSA—gonad—hypothyroidism	0.00595	0.00886	CbGeAlD
Suramin—SIRT5—female gonad—hypothyroidism	0.00591	0.0088	CbGeAlD
Suramin—SIRT1—pituitary gland—hypothyroidism	0.00588	0.00875	CbGeAlD
Suramin—ARSA—pituitary gland—hypothyroidism	0.0058	0.00864	CbGeAlD
Suramin—P2RX4—thyroid gland—hypothyroidism	0.00578	0.00861	CbGeAlD
Suramin—P2RX4—female gonad—hypothyroidism	0.00559	0.00832	CbGeAlD
Suramin—SIRT1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00535	0.0163	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—TRH—hypothyroidism	0.00531	0.0162	CbGpPWpGaD
Suramin—SIRT1—adrenal gland—hypothyroidism	0.00525	0.00782	CbGeAlD
Suramin—SIRT1—blood—hypothyroidism	0.00525	0.00782	CbGeAlD
Suramin—SIRT5—testis—hypothyroidism	0.00524	0.0078	CbGeAlD
Suramin—ARSA—adrenal gland—hypothyroidism	0.00518	0.00772	CbGeAlD
Suramin—ARSA—blood—hypothyroidism	0.00518	0.00772	CbGeAlD
Suramin—PLA2G2A—adrenal cortex—hypothyroidism	0.00509	0.00758	CbGeAlD
Suramin—SIRT1—thyroid gland—hypothyroidism	0.00507	0.00754	CbGeAlD
Suramin—ARSA—thyroid gland—hypothyroidism	0.005	0.00745	CbGeAlD
Suramin—P2RX4—testis—hypothyroidism	0.00495	0.00738	CbGeAlD
Suramin—SIRT5—liver—hypothyroidism	0.00495	0.00738	CbGeAlD
Suramin—PLA2G2A—heart—hypothyroidism	0.00492	0.00733	CbGeAlD
Suramin—SIRT1—female gonad—hypothyroidism	0.00489	0.00729	CbGeAlD
Suramin—RYR1—adrenal gland—hypothyroidism	0.00485	0.00722	CbGeAlD
Suramin—RYR1—blood—hypothyroidism	0.00485	0.00722	CbGeAlD
Suramin—SIRT5—cerebellum—hypothyroidism	0.00484	0.00721	CbGeAlD
Suramin—ARSA—female gonad—hypothyroidism	0.00483	0.0072	CbGeAlD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00475	0.0145	CbGpPWpGaD
Suramin—P2RX4—liver—hypothyroidism	0.00468	0.00697	CbGeAlD
Suramin—RYR1—thyroid gland—hypothyroidism	0.00468	0.00697	CbGeAlD
Suramin—PLA2G2A—cardiovascular system—hypothyroidism	0.00465	0.00692	CbGeAlD
Suramin—P2RX4—cerebellum—hypothyroidism	0.00458	0.00681	CbGeAlD
Suramin—F2—Complement and Coagulation Cascades—CLTC—hypothyroidism	0.00442	0.0135	CbGpPWpGaD
Suramin—SIRT1—testis—hypothyroidism	0.00434	0.00646	CbGeAlD
Suramin—ARSA—testis—hypothyroidism	0.00429	0.00639	CbGeAlD
Suramin—PLA2G2A—pituitary gland—hypothyroidism	0.00411	0.00613	CbGeAlD
Suramin—SIRT1—liver—hypothyroidism	0.0041	0.00611	CbGeAlD
Suramin—ARSA—liver—hypothyroidism	0.00405	0.00604	CbGeAlD
Suramin—RYR1—testis—hypothyroidism	0.00401	0.00597	CbGeAlD
Suramin—SIRT1—cerebellum—hypothyroidism	0.00401	0.00597	CbGeAlD
Suramin—ARSA—cerebellum—hypothyroidism	0.00396	0.0059	CbGeAlD
Suramin—RYR1—liver—hypothyroidism	0.00379	0.00565	CbGeAlD
Suramin—FSHR—G alpha (s) signalling events—AVP—hypothyroidism	0.00374	0.0114	CbGpPWpGaD
Suramin—F2—heart—hypothyroidism	0.00372	0.00554	CbGeAlD
Suramin—RYR1—cerebellum—hypothyroidism	0.0037	0.00552	CbGeAlD
Suramin—PLA2G2A—adrenal gland—hypothyroidism	0.00368	0.00547	CbGeAlD
Suramin—PLA2G2A—blood—hypothyroidism	0.00367	0.00547	CbGeAlD
Suramin—PLA2G2A—thyroid gland—hypothyroidism	0.00355	0.00528	CbGeAlD
Suramin—PLA2G4A—adrenal cortex—hypothyroidism	0.00354	0.00527	CbGeAlD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00354	0.0108	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00352	0.0107	CbGpPWpGaD
Suramin—F2—cardiovascular system—hypothyroidism	0.00351	0.00522	CbGeAlD
Suramin—PLA2G2A—female gonad—hypothyroidism	0.00343	0.0051	CbGeAlD
Suramin—PLA2G4A—heart—hypothyroidism	0.00342	0.0051	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0034	0.0103	CbGpPWpGaD
Suramin—PLA2G4A—cardiovascular system—hypothyroidism	0.00323	0.00481	CbGeAlD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00314	0.00954	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00314	0.00954	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ZNF764—hypothyroidism	0.00306	0.00933	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00306	0.00931	CbGpPWpGaD
Suramin—PLA2G2A—testis—hypothyroidism	0.00304	0.00453	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00303	0.00922	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00303	0.00922	CbGpPWpGaD
Suramin—PLA2G2A—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00299	0.00909	CbGpPWpGaD
Suramin—F2—Regulation of IGF Activity by IGFBP—IGF1—hypothyroidism	0.00293	0.00892	CbGpPWpGaD
Suramin—PLA2G2A—liver—hypothyroidism	0.00287	0.00428	CbGeAlD
Suramin—PLA2G4A—pituitary gland—hypothyroidism	0.00286	0.00426	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—AVP—hypothyroidism	0.00279	0.00849	CbGpPWpGaD
Suramin—F2—adrenal gland—hypothyroidism	0.00277	0.00413	CbGeAlD
Suramin—F2—blood—hypothyroidism	0.00277	0.00413	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—TRH—hypothyroidism	0.00268	0.00815	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00263	0.00802	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—TRH—hypothyroidism	0.00259	0.00788	CbGpPWpGaD
Suramin—F2—female gonad—hypothyroidism	0.00259	0.00385	CbGeAlD
Suramin—PLA2G4A—adrenal gland—hypothyroidism	0.00256	0.00381	CbGeAlD
Suramin—PLA2G4A—blood—hypothyroidism	0.00255	0.0038	CbGeAlD
Suramin—RYR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00253	0.00771	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.0025	0.0076	CbGpPWpGaD
Suramin—FSHR—G alpha (s) signalling events—POMC—hypothyroidism	0.00249	0.00757	CbGpPWpGaD
Suramin—PLA2G4A—thyroid gland—hypothyroidism	0.00247	0.00367	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—TSHB—hypothyroidism	0.00239	0.00727	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—TSHR—hypothyroidism	0.00239	0.00727	CbGpPWpGaD
Suramin—PLA2G4A—female gonad—hypothyroidism	0.00238	0.00355	CbGeAlD
Suramin—FSHR—GPCR ligand binding—TSHB—hypothyroidism	0.00231	0.00702	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—TSHR—hypothyroidism	0.00231	0.00702	CbGpPWpGaD
Suramin—F2—liver—hypothyroidism	0.00217	0.00323	CbGeAlD
Suramin—PLA2G4A—testis—hypothyroidism	0.00211	0.00315	CbGeAlD
Suramin—SIRT1—Circadian rythm related genes—AVP—hypothyroidism	0.00203	0.00619	CbGpPWpGaD
Suramin—ARSA—Metabolism—IYD—hypothyroidism	0.00201	0.00613	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—THRA—hypothyroidism	0.00198	0.00601	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00188	0.00571	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00185	0.00563	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00178	0.00543	CbGpPWpGaD
Suramin—ARSA—Metabolism—ATP5O—hypothyroidism	0.00171	0.00521	CbGpPWpGaD
Suramin—ARSA—Metabolism—TPO—hypothyroidism	0.00161	0.0049	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—TRH—hypothyroidism	0.00152	0.00462	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TRH—hypothyroidism	0.00151	0.00461	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0015	0.00456	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00149	0.00454	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TRH—hypothyroidism	0.00146	0.00445	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00145	0.0044	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—TSHB—hypothyroidism	0.00145	0.0044	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AVP—hypothyroidism	0.00141	0.00428	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NKX2-5—hypothyroidism	0.00141	0.00428	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00141	0.00428	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TRH—hypothyroidism	0.00137	0.00418	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AVP—hypothyroidism	0.00136	0.00414	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00136	0.00413	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00135	0.00412	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TSHB—hypothyroidism	0.00135	0.00411	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TSHR—hypothyroidism	0.00135	0.00411	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TRH—hypothyroidism	0.00133	0.00404	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TSHB—hypothyroidism	0.0013	0.00397	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TSHR—hypothyroidism	0.0013	0.00397	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—IYD—hypothyroidism	0.0013	0.00395	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—THRB—hypothyroidism	0.00127	0.00387	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00123	0.00374	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TSHB—hypothyroidism	0.00123	0.00373	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TSHR—hypothyroidism	0.00123	0.00373	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00122	0.00372	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00119	0.00361	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TSHB—hypothyroidism	0.00118	0.0036	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TSHR—hypothyroidism	0.00118	0.0036	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ATP5O—hypothyroidism	0.0011	0.00336	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TPO—hypothyroidism	0.00104	0.00316	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00101	0.00306	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000962	0.00293	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000961	0.00293	CbGpPWpGaD
Suramin—PLA2G4A—Opioid Signalling—POMC—hypothyroidism	0.000947	0.00288	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CLTC—hypothyroidism	0.00094	0.00286	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—POMC—hypothyroidism	0.000935	0.00285	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CLTC—hypothyroidism	0.000908	0.00276	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—POMC—hypothyroidism	0.000903	0.00275	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000896	0.00273	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000896	0.00273	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—VAV3—hypothyroidism	0.000826	0.00251	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TRH—hypothyroidism	0.000812	0.00247	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—AVP—hypothyroidism	0.000797	0.00243	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—VAV3—hypothyroidism	0.000797	0.00243	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AVP—hypothyroidism	0.000795	0.00242	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000787	0.0024	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TRH—hypothyroidism	0.000784	0.00239	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AVP—hypothyroidism	0.000768	0.00234	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TRH—hypothyroidism	0.000766	0.00233	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—VAV3—hypothyroidism	0.00075	0.00228	CbGpPWpGaD
Suramin—ARSA—Metabolism—TSHB—hypothyroidism	0.000745	0.00227	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000724	0.0022	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—VAV3—hypothyroidism	0.000724	0.0022	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TSHB—hypothyroidism	0.000724	0.0022	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TSHR—hypothyroidism	0.000724	0.0022	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AVP—hypothyroidism	0.000722	0.0022	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000713	0.00217	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TSHB—hypothyroidism	0.000699	0.00213	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TSHR—hypothyroidism	0.000699	0.00213	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AVP—hypothyroidism	0.000698	0.00212	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TSHB—hypothyroidism	0.000682	0.00208	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TSHR—hypothyroidism	0.000682	0.00208	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3C2A—hypothyroidism	0.000664	0.00202	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000662	0.00202	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000655	0.00199	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SH2B3—hypothyroidism	0.000645	0.00196	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SH2B3—hypothyroidism	0.000623	0.0019	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—IYD—hypothyroidism	0.000611	0.00186	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—POMC—hypothyroidism	0.000566	0.00172	CbGpPWpGaD
Suramin—ARSA—Metabolism—SLC5A5—hypothyroidism	0.000558	0.0017	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGF1—hypothyroidism	0.000545	0.00166	CbGpPWpGaD
Suramin—F2—Hemostasis—SH2B3—hypothyroidism	0.000544	0.00166	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—POMC—hypothyroidism	0.000529	0.00161	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000528	0.00161	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000523	0.00159	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ATP5O—hypothyroidism	0.00052	0.00158	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—POMC—hypothyroidism	0.00051	0.00155	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SH2B3—hypothyroidism	0.000497	0.00151	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPO—hypothyroidism	0.000489	0.00149	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TSHB—hypothyroidism	0.00048	0.00146	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TSHB—hypothyroidism	0.00048	0.00146	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—POMC—hypothyroidism	0.00048	0.00146	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PRL—hypothyroidism	0.000479	0.00146	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—POMC—hypothyroidism	0.000464	0.00141	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PRL—hypothyroidism	0.000462	0.00141	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000458	0.0014	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000453	0.00138	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000446	0.00136	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VAV3—hypothyroidism	0.000443	0.00135	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TRH—hypothyroidism	0.000433	0.00132	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3C2A—hypothyroidism	0.000428	0.0013	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VAV3—hypothyroidism	0.000428	0.0013	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AVP—hypothyroidism	0.000427	0.0013	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000422	0.00129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AVP—hypothyroidism	0.000412	0.00125	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000408	0.00124	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AVP—hypothyroidism	0.000402	0.00122	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TRH—hypothyroidism	0.000393	0.0012	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TSHB—hypothyroidism	0.000386	0.00117	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TSHR—hypothyroidism	0.000386	0.00117	CbGpPWpGaD
Suramin—F2—Hemostasis—VAV3—hypothyroidism	0.000373	0.00114	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SLC5A5—hypothyroidism	0.00036	0.00109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TRH—hypothyroidism	0.000359	0.00109	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000351	0.00107	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TSHB—hypothyroidism	0.00035	0.00107	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TSHR—hypothyroidism	0.00035	0.00107	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VAV3—hypothyroidism	0.000341	0.00104	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TSHB—hypothyroidism	0.00032	0.000975	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TSHR—hypothyroidism	0.00032	0.000975	CbGpPWpGaD
Suramin—ARSA—Metabolism—POMC—hypothyroidism	0.000292	0.000888	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—POMC—hypothyroidism	0.000284	0.000863	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—POMC—hypothyroidism	0.000274	0.000833	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1—hypothyroidism	0.000273	0.00083	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CLTC—hypothyroidism	0.000269	0.000817	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—POMC—hypothyroidism	0.000267	0.000813	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1—hypothyroidism	0.000263	0.000802	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CLTC—hypothyroidism	0.000246	0.000748	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—VAV3—hypothyroidism	0.000236	0.000718	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TRH—hypothyroidism	0.000232	0.000706	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—hypothyroidism	0.00023	0.0007	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AVP—hypothyroidism	0.000227	0.000692	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TSHB—hypothyroidism	0.000226	0.000689	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—VAV3—hypothyroidism	0.000214	0.000652	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TRH—hypothyroidism	0.000212	0.000646	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—hypothyroidism	0.00021	0.00064	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TSHB—hypothyroidism	0.000207	0.00063	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TSHR—hypothyroidism	0.000207	0.00063	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AVP—hypothyroidism	0.000206	0.000628	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3C2A—hypothyroidism	0.000202	0.000614	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000199	0.000606	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—VAV3—hypothyroidism	0.000196	0.000596	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TSHB—hypothyroidism	0.000189	0.000576	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TSHR—hypothyroidism	0.000189	0.000576	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AVP—hypothyroidism	0.000189	0.000575	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—POMC—hypothyroidism	0.000188	0.000572	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—POMC—hypothyroidism	0.000188	0.000572	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SH2B3—hypothyroidism	0.000184	0.000561	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—hypothyroidism	0.000181	0.00055	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC5A5—hypothyroidism	0.000169	0.000516	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SH2B3—hypothyroidism	0.000169	0.000513	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—POMC—hypothyroidism	0.000151	0.00046	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—POMC—hypothyroidism	0.000137	0.000417	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRL—hypothyroidism	0.000137	0.000416	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VAV3—hypothyroidism	0.000127	0.000385	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—POMC—hypothyroidism	0.000125	0.000382	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRL—hypothyroidism	0.000125	0.000381	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AVP—hypothyroidism	0.000122	0.000371	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VAV3—hypothyroidism	0.000116	0.000352	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AVP—hypothyroidism	0.000112	0.000339	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—POMC—hypothyroidism	8.86e-05	0.00027	CbGpPWpGaD
Suramin—F2—Signaling Pathways—POMC—hypothyroidism	8.1e-05	0.000247	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—hypothyroidism	7.79e-05	0.000237	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—POMC—hypothyroidism	7.41e-05	0.000226	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—hypothyroidism	7.13e-05	0.000217	CbGpPWpGaD
